Naftidrofuryl oxalate - Peripheral arterial disease
You are here : Home > Formulary Search > Naftidrofuryl oxalate - Peripheral arterial disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
NICE Technology Appraisal
PAD Profile
ChemicalSubstance :
Naftidrofuryl oxalate
Indication :
Peripheral arterial disease
Group Name :
Keywords :
Intermittent claudication, peripheral vascular disease, atherosclerosis,
Brand Names Include :
Praxilene
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Naftidrofuryl oxalate is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Peripheral arterial disease.
Committee Recommendations (1)
GENERIC Naftidrofuryl has been considered by the PCN and has been assigned a GREEN traffic light status.
NOTE - the branded product, Praxilene, was considered BLACK at the PCN in May 2017.
NOTE - the branded product, Praxilene, was considered BLACK at the PCN in May 2017.